Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thailand To Change “Dominant Position” Definition Of Drug Market Share

This article was originally published in PharmAsia News

Executive Summary

Thailand's Commerce Ministry plans to fix a loophole used by Abbott Laboratories to avoid certain trade competition restrictions. The company withdrew an application to register 10 new drugs in the country last year in response to a government decision to use compulsory licensing to enable production of generic versions of an Abbott HIV/AIDS drug. The Trade Competition Act Committee of the Thai ministry said the law turns on the definition of "dominant position" for products, so the definition is to be changed from applying to those with 50 percent of market share to those with just 25-30 percent. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066683

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel